Increased malondialdehyde levels in coronary heart disease

M A Khan1, A Baseer

  • 1Department of Biochemistry, Jinnah Post Graduate Medical Centre, Karachi.

Insights

Coronary heart disease patients exhibit elevated lipid peroxidation, indicated by higher malondialdehyde levels. Smoking further exacerbates this lipid peroxidation in patients with coronary heart disease.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Oxidative Stress Research

Background:

  • Lipid peroxidation is a key process in oxidative stress.
  • Oxidative stress is implicated in the development of cardiovascular diseases.
  • Understanding lipid peroxidation markers is crucial for assessing cardiovascular disease risk.

Purpose of the Study:

  • To compare lipid peroxidation status between coronary heart disease (CHD) patients and healthy controls.
  • To investigate the impact of smoking on lipid peroxidation in CHD patients.

Main Methods:

  • Serum levels of malondialdehyde (MDA), total cholesterol, triglycerides, HDL-C, and LDL-C were measured.
  • The study included 46 CHD patients and 50 age-matched healthy controls.
  • CHD patients were stratified into smokers and non-smokers to assess smoking's effect.

Main Results:

  • CHD patients showed significantly higher MDA and lipid parameters (except HDL-C, which was lower) compared to controls (P < 0.001).
  • Smokers with CHD had significantly higher MDA levels than non-smokers with CHD (P < 0.025).

Conclusions:

  • Elevated serum MDA suggests increased oxygen free radical production in CHD.
  • These findings support a role for oxidative stress and lipid peroxidation in atherogenesis and CHD development.
  • Smoking appears to augment lipid peroxidation in individuals with coronary heart disease.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...